Camber Capital Management L.P. is an investment fund managing more than $2.57 billion ran by Stephen Dubois. There are currently 34 companies in Mr. Dubois’s portfolio. The largest investments include Zimmer Biomet Inc and Baxter International, together worth $393 million.
As of 7th August 2024, Camber Capital Management L.P.’s top holding is 1,925,000 shares of Zimmer Biomet Inc currently worth over $209 million and making up 8.1% of the portfolio value.
Relative to the number of outstanding shares of Zimmer Biomet Inc, Camber Capital Management L.P. owns more than approximately 0.1% of the company.
In addition, the fund holds 5,500,000 shares of Baxter International worth $184 million, whose value fell 12.9% in the past six months.
The third-largest holding is Medtronic Plc worth $177 million and the next is Universal Hlth Svcs Inc worth $176 million, with 950,000 shares owned.
Currently, Camber Capital Management L.P.'s portfolio is worth at least $2.57 billion. The total portfolio value may be much higher due to cash
assets that are not publicly disclosed such as fixed income, real estate, or cash equivalents.
The Camber Capital Management L.P. office and employees reside in Boston, Massachusetts. According to the last 13-F report filed with the SEC, Stephen Dubois serves as the Managing Member at Camber Capital Management L.P..
In the most recent 13F filing, Camber Capital Management L.P. revealed that it had opened a new position in
Humana and bought 400,000 shares worth $149 million.
This means they effectively own approximately 0.1% of the company.
Humana makes up
8.5%
of the fund's Health Care sector allocation and has decreased its share price by 28.2% in the past year.
The investment fund also strengthened its position in Baxter International by buying
500,000 additional shares.
This makes their stake in Baxter International total 5,500,000 shares worth $184 million.
Baxter International dropped 19.4% in the past year.
On the other hand, there are companies that Camber Capital Management L.P. is getting rid of from its portfolio.
Camber Capital Management L.P. closed its position in Tenet Healthcare on 14th August 2024.
It sold the previously owned 1,900,000 shares for $200 million.
Stephen Dubois also disclosed a decreased stake in Universal Hlth Svcs Inc by 0.2%.
This leaves the value of the investment at $176 million and 950,000 shares.
The two most similar investment funds to Camber Capital Management L.P. are Raine and Braun Stacey Associates Inc. They manage $2.57 billion and $2.58 billion respectively.
Camber Capital Management L.P.’s portfolio is diversified across 3 sectors.
Currently, their heaviest sector is Health Care — making up 68.3% of
the total portfolio value.
The fund focuses on investments in the United States as
50.0% of the portfolio companies
are based in the United States.
The majority of the companies in the fund’s portfolio are large-cap stocks.
Stocks with a size of more than $10 billion in market cap make up
32% of the total holdings value.
On the other hand, small-cap stocks make up only approximately 0.1% of the portfolio.
The average market cap of the portfolio companies is close to $23.7 billion.
These positions were updated on August 14th based on the fund’s latest 13F filing. Quickly find out what the most recently closed or increased positions are.
| Security | Shares Owned | Value | Allocation |
|---|---|---|---|
| Zimmer Biomet Holdings Inc |
No change
1,925,000
|
$208,920,000 | 8.14% |
| Tenet Healthcare Corp. |
Closed
1,900,000
|
$199,709,000 | |
| Baxter International Inc. |
10.00%
5,500,000
|
$183,975,000 | 7.16% |
| Medtronic Plc |
21.62%
2,250,000
|
$177,098,000 | 6.90% |
| Universal Hlth Svcs Inc |
24.00%
950,000
|
$175,684,000 | 6.84% |
| Globus Med Inc |
No change
2,500,000
|
$171,225,000 | 6.67% |
| Viatris Inc. |
7.69%
15,000,000
|
$159,450,000 | 6.21% |
| Humana Inc. |
Opened
400,000
|
$149,460,000 | 5.82% |
| Myriad Genetics, Inc. |
27.96%
5,500,000
|
$134,530,000 | 5.24% |
| Jazz Pharmaceuticals plc |
No change
1,150,000
|
$122,740,000 | 4.78% |
| PTC Therapeutics Inc |
12.50%
3,500,000
|
$107,030,000 | 4.17% |
| Brookdale Sr Living Inc |
No change
15,500,000
|
$105,865,000 | 4.12% |
| GSK Plc |
22.99%
2,675,000
|
$102,988,000 | 4.01% |
| Biomarin Pharmaceutical Inc. |
340.00%
1,100,000
|
$90,563,000 | 3.53% |
| Select Med Hldgs Corp |
25.00%
2,550,000
|
$89,403,000 | 3.48% |
| CVS Health Corp |
Opened
1,500,000
|
$88,590,000 | 3.45% |
| Biogen Inc |
Closed
400,000
|
$86,252,000 | |
| Walgreens Boots Alliance Inc |
10.26%
7,000,000
|
$84,665,000 | 3.30% |
| Qiagen NV |
23.97%
1,500,000
|
$61,635,000 | 2.40% |
| Zimvie Inc |
No change
3,250,000
|
$59,313,000 | 2.31% |
| Denali Therapeutics Inc |
33.33%
2,000,000
|
$46,440,000 | 1.81% |
| Perrigo Co Plc |
No change
1,520,000
|
$39,034,000 | 1.52% |
| Collegium Pharmaceutical Inc |
Closed
852,900
|
$33,110,000 | |
| Herbalife Ltd |
No change
3,000,000
|
$31,170,000 | 1.21% |
| Argenx Se |
Opened
72,000
|
$30,963,000 | 1.21% |
| Sarepta Therapeutics Inc |
74.36%
150,000
|
$23,700,000 | 0.92% |
| Peloton Interactive Inc |
Closed
4,500,000
|
$19,283,000 | |
| Bicycle Therapeutics plc |
103.33%
915,000
|
$18,520,000 | 0.72% |
| Orasure Technologies Inc. |
No change
4,250,000
|
$18,105,000 | 0.71% |
| Inogen Inc |
No change
2,000,000
|
$16,260,000 | 0.63% |
| Moonlake Immunotherapeutics |
Opened
355,000
|
$15,609,000 | 0.61% |
| AnaptysBio Inc |
Opened
500,000
|
$12,530,000 | 0.49% |
| Replimune Group Inc |
50.91%
1,350,000
|
$12,150,000 | 0.47% |
| Evolent Health Inc |
Opened
625,000
|
$11,950,000 | 0.47% |
| Puma Biotechnology Inc |
Closed
1,650,000
|
$8,745,000 | |
| Theravance Biopharma Inc |
No change
1,000,000
|
$8,480,000 | 0.33% |
| The Beauty Health Company |
No change
3,500,000
|
$6,720,000 | 0.26% |
| Curevac N V |
68.57%
550,000
|
$1,870,000 | 0.07% |
| Genmab A/s |
No change
50,000
|
$1,257,000 | 0.05% |
| No transactions found | |||
| Showing first 500 out of 39 holdings | |||